IBB
$170.10iShares Biotechnology ETF
NASDAQ biotech and pharmaceutical companies.
Expense ratio
0.44%
Dividend yield
0.23%
AUM
$7.95B
Issuer
iShares
YTD return
3.10%
1Y return
—
5Y return
—
10Y return
—
Top holdings
Top holdings · IBB
| AMGN | Amgen Inc | 7.37% |
| GILD | Gilead Sciences Inc | 7.32% |
| VRTX | Vertex Pharmaceuticals Inc | 7.21% |
| REGN | Regeneron Pharmaceuticals Inc | 6.55% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.71% |
| ARGX | argenx SE ADR | 3.33% |
| INSM | Insmed Inc | 2.70% |
| BIIB | Biogen Inc | 2.67% |
| NTRA | Natera Inc | 2.40% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.27% |
Sector exposure
Sector breakdown · IBB
Healthcare100.0%